Patenting around nuisance prior art
Article Abstract:
Nuisance prior art in patent law means art that seems to laymen, but not to someone of ordinary skill in the field, to anticipate or obviate a later genuine invention. Nuisance art fails to help the public reproduce the inventions described because they have not actually been reduced to practice. Patent applicants and their counsel should persist despite the confusion generated by nuisance art and should concentrate on protecting the validity of their inventions.
Publication Name: Journal of the Patent and Trademark Office Society
Subject: Law
ISSN: 0882-9098
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
Patenting gene sequences
Article Abstract:
The US Patent Office often accepts broad-scope detailed claims in reviewing biotechnological patents for gene sequences, cloned genes, or similar DNA-related matters, according to data from a Lexis search of issued patents. Despite a general correlation between the scope of claims and the related specification, variable amounts of supporting evidence were presented for hybridization or other broad-scope claims.
Publication Name: Journal of the Patent and Trademark Office Society
Subject: Law
ISSN: 0882-9098
Year: 1996
User Contributions:
Comment about this article or add new information about this topic:
Patenting nucleotide and amino acid sequences in view of electronic sequence database searches
Article Abstract:
Electronic databases can be used in the patent process for amino acid and nucleotide sequences. Database searching requires sequence editing, creation of a search request and interpretation of search results. There are at least seven databases which could be searched. A search could result in prior art rejection by section 102 of the Patent Code.
Publication Name: Journal of the Patent and Trademark Office Society
Subject: Law
ISSN: 0882-9098
Year: 1993
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Protecting your medical privacy. Renovating the CRA. Does medical privacy measure up?
- Abstracts: The content and focus of Canadian corporate codes of ethics. St. Vincent de Paul and business ethics
- Abstracts: Getting beyond the managed care backlash. Health insurance: the consequences of COBRA. State mandates on private insurance
- Abstracts: Outstanding Service Award. An award for P.J. "Pat" Federico. Public use and on sale issues arising from clinical testing of medical devices
- Abstracts: Establishing legal accountability for anonymous communication in cyberspace. Fighting words and fighting freestyle: the constitutionality of penalty enhancement for bias crimes